Combivir

This page contains recent news articles, when available, and an overview of Combivir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Gary Leigh says more debate is needed on HIV prevention (Photo ...  -  ‎Aug 14, 2009‎
PEP (post-exposure prophylaxis) is a 28-day course of the Aids drugs Combivir and Kaletra that, if taken within 72 hours after exposure to HIV, PinkNews.co.uk

Preocupa a familias posible cierre de parque  -  ‎Aug 17, 2009‎
...esto si es importante que atender, en los parques es donde se reunen las familias a combivir de forma sana, es donde se divierten los niños,es donde se El Siglo de Torreón

HIV and ARV Therapy Accelerate Bone Loss  -  ‎Jun 30, 2009‎
The study volunteers took either Kaletra (lopinavir/ritonavir) plus Combivir or Kaletra plus the non-nucleoside reverse transcriptase inhibitor (NNRTI) AIDSmeds.com HIV/AIDS Treatment News

Gilead Initiates Phase II Clinical Trial Of Integrase-Based ...  -  20 Apr 2009
Due to similarities between Emtriva and lamivudine, Atripla should not be coadministered with drugs containing lamivudine, including Combivir® Medical News Today (press release)

Anuncian farmacéuticas acuerdo para crear compañía especializada ...  -  20 Apr 2009
El nuevo corporativo tendrá una cartera de 11 productos a la venta e incluye tratamientos líderes del mercado como Combivir, Kivexa y Selzentry. ENEWSPAPER

�?��?�벌 화�?��?/GSK, �?�?�즈사업�? �? 잡았다  -  20 Apr 2009
...�?�러한 제휴는 GSK�?� 주요 HIV �?�약품�?� Combivir�?� 특허가 내년�? 만료�?�고 질레드(Gilead) 제약회사 등 미국 제약집단�?� 경�?�?� �?대�?� 우려�?서 추진�?� 것�?�다. 메디포뉴스

Gilead initiiert Phase II klinischer Studie zur HIV-Behandlung ...  -  20 Apr 2009
Dazu gehören Combivir ® (Lamivudin/Zidovudin), Epivir ® und Epivir-HBV ® (Lamivudin), Epzicom™ (Abacavirsulfat/Lamivudin) sowie Trizivir Business Wire (press release)

Glaxo, Pfizer in HIV drug deal  -  ‎Apr 17, 2009‎
The two companies had combined HIV sales of $2.4 billion last year, including GlaxoSmithKline's top-sellers Combivir and Epzicom. Combivir, which generated Philadelphia Inquirer

GSK and Pfizer join forces to create HIV company  -  ‎Apr 17, 2009‎
The as-yet-unnamed company will have 11 products on the market, led by GSK's Combivir (zidovudine and lamivudine), Kivexa (abacavir and lamivudine) and Pharma Times

Gilead Whistleblower Suit: A Bullet Dodged  -  ‎Apr 7, 2009‎
The suit describes Gilead’s drug marketing, beginning with Gilead’s 2004 plan to encourage doctors to switch their patients from GlaxoSmithKline’s Combivir BNET

TWO pharmaceutical giants are to form  -  ‎Apr 16, 2009‎
They start with 11 current products, including GSK's Combivir and Pfizer's Selzentry with six more in development. Gsk chief executive Andrew Witty said: Glasgow Daily Record

Gilead Initiates Phase II Clinical Trial of Integrase-Based ...  -  ‎Apr 17, 2009‎
Truvada should not be coadministered with Atripla, Emtriva, Viread or lamivudine-containing products, including Combivir ® (lamivudine/zidovudine), Business Wire (press release)

MedCity morning read, Thursday, April 16  -  ‎Apr 16, 2009‎
These marketed drugs include market-leading therapies Combivir, Kivexa and Selzentry/Celsentri, according to a Dow Jones report (Wall Street Journal MedCity News

A Boon For HIV Drugs?  -  ‎Apr 9, 2009‎
Earlier use of antiviral drugs like Viread, Sustiva and Combivir would boost sales for their makers. The biggest winner would likely be Foster City, Calif. Forbes

Bone loss during HIV treatment most associated with protease ...  -  ‎Apr 17, 2009‎
Combivir (AZT and 3TC) was the most widely prescribed NRTI combination (86%), and only one individual was treated with tenofovir (Viread). Aidsmap

glaxosmithkline and Pfizer to Create New HIV Company  -  ‎Apr 16, 2009‎
The new company will have a broad product portfolio from the two companies including drug therapies such as Combivir, Kivexa and Selzentry/Celsentri. Comtex Smartrend

Glaxo and Pfizer Join Forces to Develop and Market HIV Drugs  -  ‎Apr 16, 2009‎
Glaxo formerly led the field with Combivir, a pill that combines two HIV drugs and is taken twice a day. But three years ago, Gilead introduced a pill that New York Times

Glaxo and Pfizer create new HIV drug company  -  ‎Apr 16, 2009‎
The new company will have several market-leading therapies, including Combivir, Epzicom/Kivexa and Pfizer's Selzentry/Celsentri. The combined portfolio had Boston Herald

Glaxo and Pfizer create new HIV drug company  -  ‎Apr 16, 2009‎
The new company will have a product portfolio of 11 marketed products including market-leading therapies such as Combivir, Kivexa and Selzentry/Celsentri. Forbes

GlaxoSmithKline and Pfizer to combine HIV businesses into new company  -  ‎Apr 16, 2009‎
The new company will have several market-leading therapies, including Combivir, Kivexa and Selzentry/Celsentri. Based on 2008 results, the combined Los Angeles Times

Las farmacéuticas Glaxo y Pfizer unen sus negocios de fármacos ...  -  ‎Apr 17, 2009‎
Ambas compañías, la primera británica y la segunda estadounidense, se fusionarán para comercializar once fármacos que producen actualmente, como Combivir y La Nueva España

葛兰素和辉瑞将创建HIV�?�物新公�?�  -  ‎Apr 16, 2009‎
...新公�?�的产�?组�?�包括11�?已上市�?�物，其中包括市场领先的Combivir�?Kivexa和Selzentry/Celsentri等�?��?。�?�2008年的业绩数字计算，这些�?�物总计产生了约16亿英镑(24 新浪网

Glaxo e Pfizer formam empresa para tratamento da AIDS  -  ‎Apr 16, 2009‎
A nova companhia terá 11 produtos comercializados --incluindo os mais vendidos da Glaxo, Combivir e Epzicom--, que juntos geraram vendas de 1,6 bilhão de Abril

GlaxoSmithKline и Pfizer подпи�?али �?оглашение о �?оздании компании ...  -  ‎Apr 16, 2009‎
Совме�?тное предпри�?тие GSK и Pfizer будет ве�?ти и�?�?ледовани�? 11 препаратов, включа�? Combivir, Kivexa и Selzentry/Celsentri, которые �?вл�?ют�?�? лидерами рынка РБК - РИА РосБизнесКонсалтинг

葛蘭素和�?瑞將創建HIV藥物新公�?�  -  ‎Apr 16, 2009‎
...新公�?�的產�?組�?�包括11種已上市藥物，其中包括市場領先的Combivir�?Kivexa和Selzentry/Celsentri等藥�?。據2008年的業績數字計算，這些藥物總計產生了約16億英鎊(24億新浪網

GlaxoSmithKline και Pfizer συγχωνε�?ουν τις μονάδες φα�?μάκων κατά ...  -  ‎Apr 16, 2009‎
Ένα από τα φά�?μακα της Glaxoκατά του ιο�? HIV με τις μεγαλ�?τε�?ες πωλήσεις, το Combivir, θα σταματήσει το 2012 να αποτελεί πατέντα, ενώ η Pfizer, Capital.gr

GSK-화�?��?, HIV치료제 개발 공�?�벤처 설립  -  ‎Apr 16, 2009‎
...새로운 벤처회사는 최대 매출품목�?� GSK�?� ‘컴비비어(Combivir)'와 '�?프지콤(Epzicom)'�?� �?�함해 시중�? 유통�?�는 11종�?� HIV제품�?� 보유하게 �??으며 6개�?� 실험약�?� 데일리팜

VIH-SIDA : une joint-venture GSK-Pfizer  -  ‎Apr 16, 2009‎
Dans un premier temps, la nouvelle structure « récupèrera » 11 produits déjà commercialisés séparément par les deux partenaires, parmi lesquels le Combivir Destination Santé

Gilead initie un essai clinique de Phase II avec un régime ...  -  ‎Apr 19, 2009‎
Le Truvada ne doit pas être administré avec de l'Atripla, de l'Emtriva, du Viread ou avec des produits contenant de la lamivudine, notamment le Combivir Euroinvestor

Track HIV medication stocks - AIDS support group  -  ‎Feb 24, 2009‎
She pointed out that a representative from the Health Corporation Ltd informed JASL that ARVs for second-line treatment, namely Combivir and Truvada, Jamaica Gleaner

One-a-day regimens mean better adherence for patients starting HIV ...  -  Jan 29, 2009
Four compared, respectively, once- versus twice-daily dosing of Kaletra, AZT/3TC (Combivir), nevirapine (Viramune) and Kivexa ,while the fifth compared the Aidsmap,

Rare abacavir liver side-effects reported  -  Dec 2, 2008
The first case involved a 26-year-old Zimbabwean women who switched from an antiretroviral regimen of Combivir (AZT and 3TC) with nevirapine (Viramune) to Aidsmap,

2008-12-11 0:31:58 �?��?:�?�年人(Qnr.Cn) 作者:Qnr.Cn  -  Dec 10, 2008
Researchers compared its ____10____ to6 that of the widely used combination of Sustiva and Combivir �?�年人,

Oι εκδόσεις Οξ�? πα�?ουσιάζουν το νέο αποκαλυπτικό βιβλίο της Μα�?ίας ...  -  Nov 30, 2008
Είχε πετάξει τα Kaletra και Combivir στο πο�?τμπαγκάζ του αυτοκινήτου της και δεν ήξε�?ε τι να τα κάνει. Θα είχαν χαλάσει κιόλας από τη ζέστη, κόστιζαν στο Avopolis,

Pfizer HIV Drug Shows Promise  -  Oct 28, 2008
More than two-thirds of HIV patients taking Pfizer’s Selzentry and GlaxoSmithKline’s Combivir had the viral load in their blood suppressed to undetectable FDA news (subscription),

Pfizer reports 'exciting' Selzentry results  -  Oct 27, 2008
Results were based on the use of Selzentry in combination with Combivir and came from a new enhanced sensitivity test known as the Trofile assay. Hays Pharma,

Avexa Presents Data from Apricitabine and Antibacterial Programs ...  -  Nov 13, 2008
Combivir(R) or Trizivir(R) (currently marketed by GlaxoSmithKline) or Emtriva(R), Truvada(R) and Atripla(R) (currently marketed by Gilead Sciences). MarketWatch

Enhanced Trofile assay better at identifying HIV tropisms, only ...  -  Oct 31, 2008
The other was the MERIT study, which evaluated maraviroc against efavirenz, in combination with AZT/3TC (Combivir). While other studies had examined Aidsmap,

Studies: Newer HIV drugs more tolerable for many  -  Oct 26, 2008
...of older data from a 48-week study comparing its Selzentry with Sustiva in a total of 417 patients also getting an HIV drug combination called Combivir. CNNMoney.com

Shire's New Product Portfolio Delivers Strong Quarterly Performance  -  Oct 29, 2008
CARBATROL(R) (carbamazepine - extended-release capsules) COMBIVIR (R) (lamivudine) (trademark of GlaxoSmithKline ("GSK")) DAYTRANA(R) (methylphenidate MarketWatch

The Global HIV AIDS Market Outlook to 2012 - New Research Report ...  -  Nov 17, 2008
The key growth driver in this drug class has been the increasing use of fixed-dose NRTI combinations, such as Gilead’s Truvada and GSK’s Combivir. Live-PR.com (Pressemitteilung),

Merck's Antiretroviral Isentress More Efficient in Suppressing HIV ...  -  Oct 28, 2008
...with Bristol-Myer Squibb's antiretroviral Sustiva in a total of 417 patients also receiving GlaxoSmithKline's antiretroviral combination drug Combivir. Kaiser network.org,

Single dose of childbirth HIV drug ‘can be fatal’  -  Nov 5, 2008
...saying the problem of nevirapine resistance can be easily fixed by giving mothers a cheap, seven-day course of combivir after their babies are born. Business Day,

Market Report -- In Play ()  -  Oct 26, 2008
On The Wires Patients taking Pfizer's (PFE) Selzentry, in combination with Combivir and selected by an enhanced sensitivity tropism test to screen patients, MSN Money

Empresas.- 'Celsentri' (Pfizer) confirma mayor tasa de eficacia en ...  -  Oct 27, 2008
Los pacientes tratados con maraviroc, comercializado por Pfizer como 'Celsentri', en combinación con 'Combivir' (zidovudina/lamivudina) experimentan una ecodiario,

A l'attention du directeur de l'information/des rédacteurs de la ...  -  Oct 29, 2008
.../CNW/ - Les patients traités par CELSENTRI(MC) qui prennent en concomitance Combivir(MD) (zidovudine/lamivudine) et qui ont été sélectionnés à l'aide d'un Canada NewsWire (press release),

Presence of Newcomers Forcing Changes in Blockbuster HIV Drug Market  -  Sep 24, 2008
Epzicom had sales of $ 404 million dollars in the first half of this year, below GSK´s own Combivir, at $ 416 million in the same period. Network Médica,

Culpa Chile a laboratorio de retraso entrega medicamento contra sida  -  Oct 11, 2008
Los medicamentos serían el Crixivan, Kaletra y Combivir, todos de distintos laboratorios internacionales, señaló la organización. Ello provocó el retraso de Milenio,

ARV shortage hits  -  Aug 22, 2008
She said whereas Combivir, the backbone of most ARV combinations in Uganda is still in stock, all others were in short supply at some sites. New Vision,

Uganda: Running out of Aids drugs  -  Aug 25, 2008
She said whereas Combivir, the backbone of most ARV combinations in Uganda is still in stock, all others were in short supply at some sites. Afika,

Tough HIV drug ads draw fire  -  Aug 25, 2008
Newer meds like Gilead Sciences' Truvada and Merck's Isentress are on the rise, and GlaxoSmithKline's older drugs--Combivir and Trizivir, for instance--are FiercePharma,

Lupin, Mahindra, Tata Steel, Tata Motors: India Stock Preview  -  Sep 3, 2008
Europe's biggest drugmaker, sued Lupin Ltd. claiming the Indian company's plan to sell a generic version of the AIDS drug Combivir infringes a US patent Bloomberg

Punch Taverns, Spirent, Vodafone: UK, Irish Equity Preview  -  Sep 2, 2008
...biggest drugmaker sued Lupin Ltd., claiming the Indian company's plan to sell a generic version of the AIDS drug Combivir infringes a US patent. Bloomberg

Glaxo's HIV-Drug Ads Draw Critics  -  Aug 24, 2008
Some of Glaxo's biggest HIV drugs, including Combivir and Trizivir, have been losing ground to newer treatments such as Truvada from Gilead Sciences Inc. Wall Street Journal

Business in the courts  -  Sep 7, 2008
GlaxoSmithKline Plc, Europe's biggest drug maker, sued Lupin Ltd., claiming the Indian company's plan to sell a generic version of the AIDS drug Combivir The News Journal,

Next generation first-line NNRTI, rilpivirine (TMC278) potent ...  -  Aug 19, 2008
75mg, or 150mg) with open-label once-daily efavirenz (600mg), in combination with either AZT/3TC (Combivir; 76%) or tenofovir/FTC (Truvada; 24%). Aidsmap,

UK Stocks Decline, Led by Vodafone, Barclays, Punch Taverns  -  Sep 3, 2008
Europe's biggest drugmaker sued Lupin Ltd., claiming the Indian company's plan to sell a generic version of the AIDS drug Combivir infringes a US patent. Bloomberg

Market Report -- Short Stories (GILD)  -  Sep 2, 2008
Last July, prescriptions for GSK's Combivir and Epzicom were down, but despite the July 4th holiday, Gilead's Ttruvada and Atripla were flat and up slightly MSN Money

Gabon : Le commerce informel des médicaments brise l’élan des ...  -  Sep 10, 2008
En 2002, GlaxoSmithKline a découvert aux Etats-Unis des flacons suspects supposés contenir 60 comprimés de Combivir (lamivudine plus zidovudine) et qui InfosPlus Gabon,

JORNAL ECONÔMICO ‘GAZETA MERCANTIL’ DESTACA QUE O INSTITUTO ...  -  Sep 3, 2008
...alegando que os planos da companhia indiana para vender uma versão genérica do Combivir, medicamento destinados a pacientes portadores do vírus HIV, Agência de Notícias da Aids,

抗艾�?�物市场分�?：市场猛扩新�?迭出  -  Sep 7, 2008
...剂Efavirenz，是惟一�?�到推�??的�?�独使用的抗艾�?�；该组最早上市的Combivir 中国医�?�网,

Efavirenz superior to lopinavir/ritonavir in very advanced HIV ...  -  Aug 6, 2008
...to receive efavirenz (n=95) or lopinavir/ritonavir (n=94), each with two nucleoside reverse transcriptase inhibitors (AZT and 3TC, dosed as Combivir). Aidsmap,

Switch to atazanavir does not reduce belly fat  -  Aug 4, 2008
A Spanish study also presented at the conference, which looked at switching from Combivir (AZT/3TC) in order to restore lost limb fat, also showed that for Aidsmap,

Gilead Sciences And Merck & Co., Inc. Agree To Register And ...  -  Aug 4, 2008
Due to similarities between emtricitabine and lamivudine, Atripla should not be coadministered with drugs containing lamivudine, including Combivir® Medical News Today (press release),

Shire Delivers Strong Quarter: Driven by $243m of New Product ...  -  Jul 31, 2008
...(carbamazepine - extended-release capsules) COMBIVIR (R) (lamivudine) (trademark of GlaxoSmithKline ("GSK")) DAYTRANA(TM) (methylphenidate transdermal MarketWatch

Gilead Sciences, Inc. Q2 2008 Earnings Call Transcript  -  Jul 31, 2008
Patients previously on Combivir continue to dominate switch patients, comprising approximately 40% of those that switched to Atripla with Epzicom comprising Seeking Alpha,

Need for vigilance: two cases of abacavir allergy despite pre ...  -  Jul 16, 2008
Treatment with abacavir was therefore stopped and a new antiretroviral regimen consisting of Combivir (3TC and AZT), tenofovir, Aidsmap,

Verbesserte Behandlungsmöglichkeit für Kinder mit HIV  -  Jul 9, 2008
Das Kombinationspräparat Combivir® (Zidovudin und Lamivudin) hat von der Europäischen Zulassungsbehörde die erweiterte Zulassung zur Anwendung bei Kindern Apotheker Zeitung,

Actu des traitements  -  Jul 31, 2008
Début juillet, des ruptures de Kaletra®, Combivir® et Truvada® nous ont été signalées. Pour les deux premières molécules, les laboratoires, comme convenu, Act Up-Paris,

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com